EARLY STAGE OF FIBROMYALGIC PAIN IN ADULTS TREATED WITH GABAPENTIN AT KOSHI ZONAL HOSPITAL
Abstract
Introduction: Early stage of fibromyalgia (FM) is characterized by generalized body ache, fatigue, restlessness sleep, impaired cognitive and anxiety with unknown etiology. The definite diagnosis and treatment for fibromyalgia are not clear, but medications and alternative treatment can help to alleviate or cure early stage of fibromyalgia, among the medications one is gabapentin.
Objective: Evaluation of Numerical pain rating scale (NPRS) of fibromyalgia by treating with gabapentin at Koshi Zonal Hospital from May 2016 to March 2018.
Methodology : In this cross-sectional study, 50 patients were selected who had already taken more than two times non-steroid anti-inflammatory drugs (NSAIDS) but pain was not relived and those patients were treated with gabapentin(100mg to 300mg) for eight weeks in early stage of fibromyalgia for evaluating pain score in NPRS and complications by using Microsoft Excel Programme.
Results: Out of 50 patients, 39 patients had good response, mean age 25.2 (range18-30 years), 37 female patients, mean female age 25.41 years (range 18-30 years), 13 male patients, mean male age 24.62 years (range 18-30 years), mean duration of illness 5.18 weeks ( 4-6 weeks).
Conclusion: Patients who were taking gabapentin displayed significant reduction in pain, better sleep, and less fatigue as well as fewer complications.
Downloads
References
2. Dedhia JD, Bone ME. Pain and fibromyalgia. Continuing education in anesthesia, critical care & pain. 2009 Aug 30;9(5):162-6.
3. Kia S, Choy E. Update on treatment guideline in fibromyalgia syndrome with a focus on pharmacology. Biomedicines. 2017 May 8;5(2):20.
4. Sarzi-Puttini P, Atzeni F, Salaffi F, Cazzola M, Benucci M, Mease PJ. A multidisciplinary approach to fibromyalgia: what is the teaching?. Best practice & research Clinical Rheumatology. 2011 Apr 1;25(2):311-9.
5. Arnold LM, Goldenberg DL, Stanford SB, Lalonde JK, Sandhu HS, Keck Jr PE, Welge JA, Bishop F, Stanford KE, Hess EV, Hudson JI. Gabapentin in the treatment of fibromyalgia: a randomized, double‐blind, placebo‐controlled, multicenter trial. Arthritis & Rheumatism. 2007 Apr; 56(4):1336-44.
6. Bellato E, Marini E, Castoldi F, Barbasetti N, Mattei L, Bonasia DE, Blonna D. Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment. Pain research and treatment. 2012;2012.
7. Cohen H. Controversies and challenges in fibromyalgia: a review and a proposal. Therapeutic advances in musculoskeletal disease. 2017 May;9(5):115-27.
8. Williams DA, Schilling S. Advances in the assessment of fibromyalgia. Rheumatic Disease Clinics. 2009 May 1;35(2):339-57.
9. Hawkins RA. Fibromyalgia: a clinical update. The Journal of the American Osteopathic Association. 2013 Sep 1;113(9):680-9.
10. Suwanee G. Treatment of Fibromyalgia Pain. US Pharm. 2016;41(3):51-4.
11. Gowans SE, Voss S, Richardson M. A randomized, controlled trial of exercise and education for individuals with fibromyalgia. Arthritis Care & Research. 1999 Apr 1;12(2):120-8.
